We are live on ! Find out more
CLOV icon

Clover Health Investments

168 hedge funds and large institutions have $353M invested in Clover Health Investments in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 33

32% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 31

19% more call options, than puts

Call options by funds: $31M | Put options by funds: $26M

4% more funds holding

Funds holding: 161168 (+7)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

13.07% less ownership

Funds ownership: 39.38%26.32% (-13%)

27% less capital invested

Capital invested by funds: $484M → $353M (-$131M)

Holders
168
Holders Change
+7
Holders Change %
+4.35%
% of All Funds
2.65%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
41
Increased
52
Reduced
33
Closed
31
Calls
$31M
Puts
$26M
Net Calls
+$5.02M
Net Calls Change
-$4.98M

CLOV Hedge Fund Activity: Q1 2022 in Review

168 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q1 2022, worth a combined $353M — down 27% from $484M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new CLOV positions and 31 closed out — a net gain of 10 holders — while 52 added to existing stakes and 33 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $9.71M. The largest seller was Greenoaks Capital Partners, exiting entirely with an estimated $92.4M sold.

  • 168 institutional investors held Clover Health Investments (CLOV) as of Q1 2022, up from 161 in Q4 2021.
  • Funds reported $353M of Clover Health Investments stock for Q1 2022, down 27% quarter-over-quarter.
  • 41 funds opened new Clover Health Investments positions in Q1 2022 and 31 closed out, a net change of +10 holders.
  • The largest Clover Health Investments buyer in Q1 2022 was D.E. Shaw & Co, an estimated $9.71M added.
  • The largest Clover Health Investments seller in Q1 2022 was Greenoaks Capital Partners, an estimated $92.4M sold.

Based on aggregated 13F filings for Q1 2022.